In the latest quarter, 13 analysts provided ratings for Albemarle ALB, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 6 | 6 | 1 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 2 | 3 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 1 | 0 |
3M Ago | 0 | 4 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Albemarle, presenting an average target of $168.85, a high estimate of $308.00, and a low estimate of $128.00. A 21.07% drop is evident in the current average compared to the previous average price target of $213.92.
Breaking Down Analyst Ratings: A Detailed Examination
The perception of Albemarle by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
David Deckelbaum | TD Cowen | Announces | Market Perform | $130.00 | - |
Christopher Parkinson | Mizuho | Lowers | Neutral | $130.00 | $152.00 |
Colin Rusch | Oppenheimer | Lowers | Outperform | $191.00 | $308.00 |
Joshua Spector | UBS | Raises | Neutral | $142.00 | $130.00 |
Corinne Blanchard | Deutsche Bank | Lowers | Hold | $135.00 | $155.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $199.00 | $200.00 |
Matthew DeYoe | B of A Securities | Lowers | Neutral | $149.00 | $154.00 |
Charles Neivert | Piper Sandler | Lowers | Underweight | $128.00 | $140.00 |
Joel Jackson | BMO Capital | Lowers | Outperform | $180.00 | $265.00 |
Arun Viswanathan | RBC Capital | Lowers | Outperform | $163.00 | $212.00 |
Joshua Spector | UBS | Lowers | Neutral | $140.00 | $253.00 |
Colin Rusch | Oppenheimer | Lowers | Outperform | $308.00 | $344.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $200.00 | $254.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Albemarle. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Albemarle compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
For valuable insights into Albemarle's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Albemarle analyst ratings.
Delving into Albemarle's Background
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the U.S. and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the U.S., Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Breaking Down Albemarle's Financial Performance
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Albemarle's remarkable performance in 3 months is evident. As of 30 September, 2023, the company achieved an impressive revenue growth rate of 10.46%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 13.09%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Albemarle's ROE stands out, surpassing industry averages. With an impressive ROE of 3.07%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Albemarle's ROA stands out, surpassing industry averages. With an impressive ROA of 1.59%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Albemarle's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.37.
How Are Analyst Ratings Determined?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.